Trial Type: Skin

ALTE2131: Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults with Cancer

LS-P-IGNYTE-3: A Randomized, Controlled, Multicenter, Phase 3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination with Nivolumab Versus Treatment of Physician’s Choice in Patients with Advanced Melanoma That Has Progressed on an Anti-PD-1 and an Anti-CTLA-4 Containing Treatment Regimen

PHO-Mind the Gap: Concordance in assessment of patient well-being between patients, primary medical team, and patient caregiver in children, adolescents, and young adults with cancer and sickle cell disease

BH-P-FLOAT: A Phase I, first-in-human, open-label, dose escalation study of the safety, tolerability, pharmacokinetics, and immunogenicity of BNT317 in patients with advanced solid tumors

A Phase 1b/2a Multi-Center, Dose Escalation and Reference Regimen-Controlled, Multi-Cohort Study to Determine the Safety and Efficacy of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy in Patients with Locally Advanced or Metastatic Cancers Following One or More Prior Therapies

LS-P-DANCE: A Phase 3 Study Of Fixed Dose Combinations Of Fianlimab And Cemiplimab Versus Relatlimab And Nivolumab In Participants With Unresectable Or Metastatic Melanoma

SWOGS2205: ICE COMPRESS: Randomized Trial of Limb Cryocompression Versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy

LS-P-MAST: A Phase 1/2, Open Label, First-In-Human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Tumor Activity of SAR445877 Administered as Monotherapy in Adults with Advanced Solid Tumors

19-027: LCI-BLPR: Lifespan Cancer Institute Disposable/Replaceable Biospecimen Labelling Protocol and Patient Registry: A Pilot Study

LS-P-COE-001-0815: Caris Molecular Intelligence® and Caris Centers of Excellence for Precision Medicine Network Outcomes Associated Repository